Cargando…
Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction
Vascular endothelial growth factor B (VEGF-B) is a critical metabolic regulator in insulin resistance, and lipid distribution. We intended to ascertain the relationship between circulating VEGF-B and non-alcoholic fatty liver disease (NAFLD) in the general public. We recruited a total of 194 general...
Autores principales: | Ye, Xiaofeng, Kong, Wen, Zafar, Mohammad Ishraq, Zeng, Junchao, Yang, Rui, Chen, Lu-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783472/ https://www.ncbi.nlm.nih.gov/pubmed/33408593 http://dx.doi.org/10.17179/excli2020-2647 |
Ejemplares similares
-
The role of vascular endothelial growth factor-B in metabolic homoeostasis: current evidence
por: Zafar, Mohammad Ishraq, et al.
Publicado: (2017) -
Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis
por: Zafar, Mohammad Ishraq, et al.
Publicado: (2018) -
Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies
por: Ye, Xiaofeng, et al.
Publicado: (2019) -
Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction
por: Pasarín, Marcos, et al.
Publicado: (2017) -
Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)